
                      (Nematoda: Anisakidae) products modulate oxidative stress and apoptosis-related biomarkers in human cell lines by unknown
RESEARCH Open Access
Anisakis pegreffii (Nematoda: Anisakidae)
products modulate oxidative stress and
apoptosis-related biomarkers in human cell
lines
Concetta Maria Messina1, Federica Pizzo1, Andrea Santulli1, Ivana Bušelić2, Mate Boban3, Stjepan Orhanović3
and Ivona Mladineo2*
Abstract
Background: In countries with elevated prevalence of zoonotic anisakiasis and high awareness of this parasitosis, a
considerable number of cases that associate Anisakis sp. (Nematoda, Anisakidae) and different bowel carcinomas
have been described. Although neoplasia and embedded larvae were observed sharing the common site affected
by chronic inflammation, no association between the nematode and malignancy were directly proved. Similarly, no
data are available about the effect of secretory and excretory products of infecting larvae at the host’s cellular level,
except in respect to allergenic interaction.
Methods: To test the mechanisms by which human non-immune cells respond to the larvae, we exposed the
fibroblast cell line HS-68 to two Anisakis products (ES, excretory/secretory products; and EC, crude extract) and
evaluated molecular markers related to stress response, oxidative stress, inflammation and apoptosis, such as p53,
HSP70, TNF-α, c-jun and c-fos, employing cell viability assay, spectrophotometry, immunoblotting and qPCR.
Results: Both Anisakis products led to increased production of reactive oxygen species (ROS), especially in EC-treated
cells. While the ES treatment induces activation of kinases suggesting inflammation and cell proliferation (or inhibition
of apoptosis), in EC-treated cells, other signaling pathways indicate the inhibition of apoptosis, marked by strong
upregulation of Hsp70. Elevated induction of p53 in fibroblasts treated by both Anisakis products, suggests a
significantly negative effect on the host DNA.
Conclusions: This study shows that in vitro cell response to Anisakis products can result in at least two different
scenarios, which in both cases lead to inflammation and DNA damage. Although these preliminary results are far from
proving a relationship between the parasite and cancer, they are the first to support the existence of conditions where
such changes are feasible.
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Background
Nematodes of genus Anisakis exhibit an indirect life-
cycle where life-stages are propagated through trophic
webs of their marine hosts. Hundreds of fish species act
as paratenic hosts and more than thirty cetacean and
pinnipeds are recognised as definitive hosts [1]. In some
Mediterranean fish species, infection levels can reach up
to 300 larvae [2]. Raw or inadequately thermally proc-
essed fishery products that are contaminated by third-
stage Anisakis larvae (L3), represent a risk factor for
men, which are accidental hosts for this nematode. This
zoonotic disease is termed anisakidosis, when caused by
any species of the family Anisakidae or anisakiasis, when
caused by any species of the genus Anisakis. Penetration
of larvae through the gastrointestinal tract induces se-
vere symptoms, although larvae fail to complete their
life-cycle in humans (reviewed by [3–5]). Anisakiasis ex-
ists in different types; gastric, intestinal and ectopic [6],
while gastroallergic anisakiasis is a form of gastric anisa-
kiasis associated with allergic symptoms (e.g. from urti-
caria to anaphylactic shock) in Anisakis-hypersensitized
patients [7, 8].
Additionally, cases that associate Anisakis sp. and dif-
ferent bowel carcinomas have been described mainly in
countries where both the prevalence of anisakiasis and
the awareness of this zoonosis is high [9–13]. It is still
unclear if two etiologies, e.g. anisakiasis and carcinoma
are related or just accidental incidences [14], but it is in-
dicative that in all reported cases, neoplasia and embed-
ded larvae share the common site affected by chronic
inflammation. Carcinogenic potential of parasitic Platy-
helminthes has been previously recognized and de-
scribed in opisthorchiasis, caused by the digenean
Opisthorchis viverrini (Trematoda: Opisthorchidae) en-
demic in southeast Asia, and schistosomiasis, caused by
the digenean Schistosoma haematobium (Trematoda:
Schistostomatidae). Opisthorchis promotes development
of bile ducts carcinoma, indirectly caused by mechanical
trauma and metabolites secreted during migration. The
consequent inflammatory reaction, fibrosis and cell pro-
liferation, epithelia hyperplasia, rodlet cells metaplasia,
hyperplastic adenomatosis, all help in building up a sus-
ceptibility to DNA damage and mutation. Elevated ex-
pression of nitric oxide synthase (NOS) and resulting
increase of nitric oxide (NO) as a product of the fulmin-
ant host immune response, causes accumulation of en-
dogenous N-nitroso compounds [15–20]. These, along
with the exogenous compounds present in the fermen-
ted fish products contaminated by Opisthorchis, induce
DNA alkylation and deamination in infected tissues, and
development of carcinoma [21, 22]. In contrast, Schisto-
soma stimulates the onset of bladder carcinoma most
likely through mutation in the KRAS gene (Kirsten rat
sarcoma viral oncogene homolog), which is one of the
three proto-oncogenes encompassed in ras group,
inlcuding HRAS (Harvey rat sarcoma viral oncogene
homolog) and NRAS (Neuroblastoma RAS viral (v-ras)
oncogene homologs). Mutations in KRAS activate its
transcription, consequently stimulating cell proliferation
and inhibition of apoptosis, two important mechanisms
that regulate the number of cells in the tissues [23].
The effects of Anisakis infection or its secretory prod-
ucts have shown contrasting results so far; in some
cases, they triggered carcinogenesis, while in others they
exhibited cytostatic activity [14, 24, 25]. For example,
Th2-associated eosinophilia and IL-4 secretion in Anisa-
kis infections have been suggested to decrease tumor
growth and initiate antitumor activity. However, Th2
dominance has been also regarded as tumor growth
stimulus that promotes angiogenesis and inhibits cell-
mediated immunity and tumor cell killing [4]. With the
exception of immune cells engaged in allergenic inter-
action with infective larvae, no data are available on the
effect of nematode secretory and excretory products at
the non-immune host cellular level, important for evalu-
ation of other pathogenic pathways of the larvae.
In line with this, the aim of our study was to test the
effect of two types of A. pegreffii products on the human
normal fibroblast cell line HS-68; one A. pegreffii prod-
uct was obtained from live and active larvae, excreted
and secreted during its tissue penetration in the host
(ES), and the other obtained as a crude extract of the
whole body of senescent larvae (EC). Subsequently, we
assessed the correlation between toxicity, oxidative
stress, apoptosis and cancer pathways by evaluating: (i)
cellular vitality; (ii) ROS production; and (iii) the expres-
sion of molecular markers related to stress response,
oxidative stress, inflammation and apoptosis, such as
p53, HSP70, TNF-α, c-jun and c-fos.
Methods
Parasite isolation and products extraction
Infective third-stage larvae (L3) of A. pegreffii were iso-
lated from visceral cavity of the Atlantic horse mackerel
(Trachurus trachurus) and morphologically identified as
Anisakis sp. based on mucron and boring tooth pres-
ence, and the appearance of the esophagus and ventricu-
lus [26] under a light microscope (Olympus, SZX10).
Excretory/secretory (ES) products were obtained as de-
scribed by [27]; larvae were washed with sterile saline,
soaked in 0.1 M glycine solution (pH 2.0) for 30 min,
and cultured in RPMI 1640 supplemented with antibi-
otics in a humid 37 °C and 5% CO2 incubator. Daily har-
vested supernatant of larval culture was filtered and
lyophilized until use, when it was resuspended in sterile
PBS. To obtain crude extract (EC), nematodes were ex-
tensively washed and subsequently homogenized by tis-
sue grinder in cold PBS using a previously described
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method [28]. Briefly, the homogenate was sonicated,
delipidized using n-hexane, centrifuged (8497⋅ g/30 min)
and supernatant dialyzed overnight in PBS at 4 °C. Pro-
tein content of products was measured following [29].
Cell culture and conditions
Human normal fibroblast cell line HS-68 was obtained
from the American Type Culture Collection (ATCC).
Cells were maintained at 37 °C and 5% CO2, and were
grown as a monolayer in flasks in DMEM supplemented
with 10% fetal bovine serum (FBS) (Gibco, Thermo-
Fisher Scientific, Waltham, MA, USA).
Both ES and EC obtained in sterile PBS were further
diluted in culture media for different treatments. For
tests of vitality and ROS production, cells were cultured
in 96-well plates, and treated 24 h afterwards. For the
assessment of dose-time effect on the vitality, cells were
treated 24, 48, 72 and 96 h with ascending doses (from
0.1 to 5%) of both products. In control wells (CO), PBS
alone was added to cells at the same volume as products
employed in treatments.
For the assessment of protein markers for oxidative,
inflammatory and carcinogenic stress, treatments were
replicated in Petri dishes in order to obtain adequate
quantities of protein and RNA to perform immunoblot-
ting and RT-PCR, respectively. At the end of the experi-
ments, cells were harvested by adding 0.5% trypsine in
PBS, centrifuged at 800⋅g/10 min and incubated for
30 min on ice in lysis buffer (1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, cocktail of protease inhibitors)
for sonication. Protein concentration was measured ac-
cording previously described methods [29].
Cell viability
Cell viability was assayed by MTT (3-(4,5-Dimethyl-
thiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) test ac-
cording to [30]. After cell exposure to products, 96-well
plates were removed from the incubator and to each
well 20 μl of MTT solution was added in dim/dark con-
ditions using a covered test tube (for the reagents). The
plate was wrapped in aluminum foil and incubated for
2 h at 37 °C. Afterwards, the contents of each well was
removed and 200 μl of lysis buffer was added to the
wells, including blank wells that served for the calibra-
tion of the plate reader. The plate was read at 590 nm
using an Opsys MR plate reader (Dynex Technologies
inc., Chantilly, VA, USA). For treated cells, viability was
expressed as a percentage in respect to the negative con-
trols. Each treatment and each concentration was done
in six replicates.
Evaluation of intracellular ROS
Intracellular ROS were analyzed on cells seeded in 96-
well microplates using the dichlorodihydrofluorescein-
diacetate (DCF-DA) method, because DCF-DA oxidizes
to dichlorodihydrofluorescein (DCF) by ROS [31]. Each
well was exposed to 10 μl of DCF-DA in HBSS (5 μg/
ml), incubated for 5 min at 37 °C to allow the oxidation
of the DCF-DA and successively read on a spectrofluo-
rometer, 485 exc - 530 em (Varian Cary Eclipse; Agilent
Technologies, Santa Clara, CA, USA). To further sup-
port the presence of ROS, additional wells were treated
with the antioxidant N-acetilcysteine that inhibits its for-
mation, according to a standardized protocol [32]. The
results were expressed as relative fluorescence/μg of
total proteins (rf/μg tp). Each treatment and each con-
centration was done in six replicates.
Immunoblotting
Levels of Hsp70, p53 and TNF protein were evaluated
by immunoblotting. Equivalent amounts of each protein
(20 μg) were separated by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to a nitrocellu-
lose membrane using a Trans Blot Turbo Transfer
System (Bio-Rad, Hercules, CA, USA). Filters were then
used for protein detection by primary antibodies; anti-
Hsp70 (rabbit monoclonal anti-Hsp70, Sigma), anti-p53
(mouse monoclonal anti-p53, Sigma), anti-TNF (rabbit
polyclonal anti-TNFSF 13B, Sigma, St Louis, MI, USA)
and the appropriate anti-mouse or anti-rabbit horserad-
ish peroxidase-conjugated secondary antibody (GAR/M-
HRP Bio-Rad). Immuno-reactive signals were detected
using enhanced chemo-luminescent (ECL) reagents
(Bio-Rad). The correct protein loading was confirmed by
red Ponceau staining. Images were obtained, visualized,
photographed and digitalized with Chemi Doc XRS
(Bio-Rad), and further analyzed with Image Lab software
(Bio-Rad) for relative quantification of the bands. The
results were expressed as a fold increase of each treat-
ment in relation to the respective control, representing
the mean value of three separate experiments.
Statistical analysis
Data are given as means ± standard deviations. The dif-
ferences among the mean values were assessed by the
Student-Newman-Keuls test. The degree of heterogen-
eity was assessed by the Cochran test. Differences were
considered significant both at P < 0.05 and P < 0.0001.
The relationship between cell viability and ROS produc-
tion was evaluated by regression analysis and correlation.
The analysis was performed using STATISTICA (version
8.0, Statsoft Inc., USA).
Real-time PCR analysis
Total cellular RNA was prepared using Aurum Total
RNA Fatty and Fibrous Tissue Kit (Bio-Rad), and con-
centrations were assessed spectrophotometrically at
260 nm. The absorbance ratios A260/A280 and A260/
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A230 were evaluated as indicators of RNA purity. Forty
nanograms of RNA were reverse-transcribed for each
sample, in a volume of 20 μl by the 5⋅ iScript Reaction
Mix Kit (Bio-Rad), according to the manufacturer’s in-
structions. Target genes for the relative quantification by
real-time PCR were p53, c-fos and c-jun, and GAPDH
and β-actin as reference genes (Table 1).
The amplification was performed in a total volume of
20 μl, which contained 0.4 μM of each primer, cDNA di-
luted 1:10 of the final reaction volume, 1⋅ IQ SYBR
Green Supermix (Bio-Rad) and nuclease-free water.
Conditions for real-time PCRs were optimized in a gra-
dient cycler (C1000 Touch Thermal Cycler, Bio-Rad)
and afterwards the following program was used: an ini-
tial activation step at 95 °C for 3 min, followed by 39 cy-
cles of 95 °C for 10 s and 60 °C for 30 s, with a single
fluorescence measurement. Melting curve data were col-
lected at 65–95 °C with heating rate of 0.5 °C/cycle and
a continuous fluorescence measurement. All reactions
were performed three times in duplicate. For each PCR,
we checked linear range of a standard curve of 6 serial
dilutions. The relative quantification of p53, c-fos, c-jun
gene expression was evaluated after normalization with
reference genes. Data processing and statistical analysis
were performed using CFX Manager Software (Bio-Rad).
Results
Cellular vitality
The effect of two products on cell vitality is shown in
Fig. 1a, b. Cell progressive reduction in vitality was not-
able in a dose-dependent manner when both Anisakis
products were used, in contrast to control treatments
(CO) that maintained 100% vitality during the whole
experiment.
All employed concentrations of ES induced a highly
significant reduction in cell vitality in respect to CO,
starting from 0.1% at 24 h (F(5,30) = 2794.7, P < 0.0001)
(Fig. 1a). In general, the same trend was observed in EC-
treated cells, in which all treatments after 24 h induced
a highly significant vitality reduction in respect to the
control (F(5,30) = 3088.8, P < 0.0001) (Fig. 1b).
The cells were affected by the toxic effect of both
treatments in a dose-time dependent manner (Fig. 1a,
b): after 96 h, cell viability treated by ES was equal to 5%
in respect to CO (F(5,30) = 2706.6, P < 0.0001), and
treated by EC was equal to 3% (F(5,30) = 3960.1, P <
0.0001).
In order to evaluate the biochemical responses of
treated cells, a 0.1% concentration of both products after
48 h was used in all downstream reactions.
ROS production
When 0.1% concentrations of ES and EC were applied
and ROS production measured 48 h post-treatment, sta-
tistically significant increase was noted compared to the
untreated control (F(3,20) = 857.83, P < 0.0001), (Fig. 1c).
Higher ROS production was observed in EC-treated cells
(P < 0.0001), while cells pretreated with the antioxidant
N-acetilcysteine expressed reduced ROS production, be-
ing protected by the compound (P < 0.0001). Regression
analysis between cell vitality and ROS demonstrated that
a relationship exists between the two variables (r2 = 0.89)
(Additional file 1: Figure S1), showing to be also highly
correlated.
Biomolecular markers of oxidative stress, inflammation
and apoptosis
An increase in p53 protein (F(2,6) = 43.9, P < 0.05) and
gene expression (F(2,12) = 17.4, P < 0.0001) levels was ob-
served after 0.1% ES and EC treatments in respect to
control (Fig. 1d and Additional file 2: Figure S2). Heat-
shock protein 70 levels were significantly increased in
EC-treated compared to control cells (F(2,6) = 269.4, P <
0.0001), as well as ES-treated cells, where expression de-
creased (Additional file 2: Figure S2). In contrast, TNF
protein was significantly increased by ES treatment
Table 1 Primer sequences of target genes used in the study
Gene Primer (5′–3′) Annealing temperature (°C) Accession number
c-jun F: GGATCAAGGCGGAGAGGAA 69 NC_018912.2
R: TCCAGCCGGGCGATT
c-fos F: TCACCCGCAGACTCCTTCTC 71.5 NC_018925.2
R: GTGGGAATGAAGTTGGCACTG
p53 F: AAGAAACCACTGGATGGAGAA 69 NC_018928.2
R: CAGCTCTCGGAACATCTCGAAA
β-actin F: AGGCTGTGCTGTCCCTGTAT 70 NC_018928.2
R: ACCCAAGAAGGAAGGCTGGA
GADPH F: ACCCACTCCTCCACCTTTGAC 72 NC_018923.2
R: GTCCACCACCCTGTTGCTGTA
Abbreviations: F forward primer, R reverse primer
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(F(2,6) = 20.6, P < 0.05) (Additional file 2: Figure S2). Gene
expression analysis of c-fos and c-jun demonstrated up-
regulation in respect to control cells, and significantly
higher levels were measured after ES treatment (F(2,12)
=76.6 P < 0.0001; F(2,12) = 54.2, P < 0.0001) (Fig. 1d).
Discussion
Two types of Anisakis products were used to simulate
different scenarios of Anisakis infection in men. Ex-
periments were performed on human fibroblast cells,
applying concentrations which in vitality tests have
proven to have the lowest toxicity and highest cell vi-
tality. In the first scenario, we used excretory and
secretory products (ES) of live larvae, mimicking the
active penetration of the parasite through the human
digestive wall. In vivo, those products encompass a
wide array of proteins and glycoproteins, localized
primarily in the parasite’s excretory glands, as well as
in the ventriculus, intestinal epithelium and basal
cuticle layer [33–36]. The largest part of ES products
act as potent allergens and immunomodulators during
parasite infection, helping larval migration [24, 34,
37], while those with low molecular mass
(<10,000 Da) have been reported to have mutagenic
properties [38]. While the distinctive feature of anisa-
kid infection are inflammatory lesions supported by
eosinophilic infiltration surrounding larval cuticle
[39], the invasive capacity of larva is correlated to se-
cretion of its anticoagulative ES products. These
products are responsible for hemorrhages close to
mechanical lesions, observed in infected gut mucosa
[28, 40]. In the second scenario, the total crude ex-
tract (EC) of larvae was used to mimic senescent or
dying larvae, because humans represent an accidental
host for anisakids where infective larvae fail to fulfil
the life-cycle and eventually die. After eliciting a po-
tent eosinophilic inflammation in the digestive tract
during migration, larvae subsequently die in four
Fig. 1 Response of fibroblast HS-68 cells lines to the treatments with Anisakis products: a Dose-dependent changes in percentage of cell vitality
(mean ± SD) after exposure to excretory/secretory (ES) products for 96 h in respect to control cells. ANOVA: ES 24 F(5,30) = 2794.7, P < 0.0001; ES 48
F(5,30) = 2969.5, P < 0.0001; ES 72 F(5,30) = 1999.3, P < 0.0001; ES 96 F(5,30) = 2706.6, P < 0.0001. b Dose-dependent changes in percentage of cell vitality
(mean ± SD) after exposure to crude extract products (EC) for 96 h in respect to control cells. ANOVA: EC 24 F(5,30) = 3088,8, P < 0.0001; EC 48 F(5,30)
= 3729.97, P < 0.0001; EC 72 F(5,30) = 4109.5, P < 0.0001; EC 96 F(5,30) = 3960.1, P < 0.0001. c Reactive oxygen species (ROS) production, expressed as
relative fluorescence/ mg total proteins (means ± SD) in cell after 48 h-exposure to 0.1% concentration of Anisakis excretory/secretory (ES) and
crude extract (EC) products ANOVA: F(3,20) = 857.83, P < 0.0001. d Fold increase (means ± SD), respect to the control cells, of p53, c-fos, c-jun and
GADPH mRNA expression after 48 h-exposure to 0.1% concentration of Anisakis excretory/secretory (ES) and crude extract (EC) products. ANOVA:
p53 F(2,12) = 17.4, P < 0.0001; c-fos F(2,12) = 76.6, P < 0.0001; c-jun F(2,12) = 54.2, P < 0.0001; GADPH F(2,12) = 0.95, P = 0.415. Abbreviations: CO, untreated
control cell lines; NAC, synthetic antioxidant N-acetilcysteine
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weeks, on average [4]. Therefore, EC represents an
admixture of ES products and all other components
of the parasite body.
Our results showed for the first time that both types
of Anisakis products lead to increased production of
oxygen reactive species (ROS) (Fig. 1c), which were
more elevated when cells were exposed to EC products.
Oxidative stress represents a misbalance in the produc-
tion of free radicals and oxygen metabolites (or reactive
oxygen species, ROS) compared to the rate of their elim-
ination by antioxidants, which consequently leads to-
ward damage of cell organelles and their biomolecules
[41]. It is postulated that ROS have a role in many dis-
eases among which chronic inflammation and cancer
have a prominent significance [42]. Phagocytes in par-
ticular inactivate pathogens mostly through the action of
cytotoxic compounds that they endogenously produce,
as highly reactive oxygen and nitrogen species (RNS)
[43, 44]. Individuals with an imbalance in ROS and RNS
production are more susceptible to infection, having an
increased rate of infection-induced mortality (reviewed
by [45]). In addition, epidemiological and experimental
studies have recognized that regardless of its cause (e.g.
biological, chemical and/or physical), the association be-
tween the chronic inflammation with an increased risk
of several human cancers is significant [46]. Up to 15–
20% of worldwide malignancies have been epidemiologi-
cally attributed to infection [47], while many cancers
have been associated with pathogens that induce strong
inflammatory response of the host, in particular the re-
lease of ROS and RNS [48]. Cells become damaged by
cytotoxic products excreted during chronic inflamma-
tion, and are consequently replaced by new cells, al-
though their genomic integrity is continuously subjected
to alteration induced by elevated ROS and RNS produc-
tion [49]. Such oxidative stress is present in all of cancer
stages; initiation, promotion, and progression [50–52],
highlighting the epidemiological importance of induced
ROS production in recurrent or chronic Anisakis
infections.
We have provided evidence that a normal fibroblast
cell line undergoes two different pathways, depending
on the type of parasitic product used for treatment.
Whilst ES products are water-soluble, EC fraction en-
compasses the extraction of different components
present in cuticle of the parasite along other products
that the larva normally excretes/secretes. Generally, in
helminth infections, including those by Anisakis, patho-
logical changes in the gastrointestinal tract result from
the interaction of the larva and its products secreted
during tissue penetration, and the complex immune re-
action of the host. Such secreted products, which are
mainly released from dorsal esophageal glands and ex-
cretory cells of the parasite, are strong proteolytic
enzymes that induce mechanical tissue damage by de-
grading the extracellular matrix [53–58]. In the case of
ES-treated cells, observed mortality of the fibroblast line
is strongly dose/time-dependent, with corresponding ex-
acerbation of oxidative stress (Fig. 1a, c). Such an envir-
onment determines the type of molecular markers
expressed, which are directed towards stimulation of in-
flammatory pathways as mechanisms of cell defense, and
apparently cell proliferation.
Observed toxicity and ROS production in treated cells
induced an increase in p53 levels, demonstrated both by
immunoblotting and RT-PCR (Fig. 1d and Additional file
2: Figure S2). Protein p53, defined as a “genome guard-
ian”, plays an intracellular key role in the maintenance
of genetic stability; it is a transcription factor with a cen-
tral role in cell response to a variety of physical and
chemical stressors, among which are agents responsible
for DNA damage, oxidative stress and hypoxia [59]. Dif-
ferent stress signals are transduced mainly by p53 cap-
acity to act as transcription factor and its regulation of
expression of numerous genes that control cell-cycle
progression, apoptosis, DNA repair and stress-response
related functions [60]. An increase in p53 is associated
with inflammation, where oxidative stress conditions are
also present [42, 61]. However, it has been demonstrated
that p53 has both a pro-oxidative [62] and anti-oxidative
effect [63]. Those contrasting effects are reflected by
p53-induced expression of pro- and anti-oxidant genes.
Antioxidative functions of p53 are associated with the
induction of target genes, among which is the glutathi-
one peroxidasis-coding gene [64]. The latter decreases
ROS levels during physiological, but not lethal stress. In
contrast, pro-oxidative effects are consequence of induc-
tion of pro-apoptotic genes, defined as PIG (p53-induced
genes), coding proteins whose activity increases intracel-
lular ROS [62]. Therefore, an increase of ROS in Anisa-
kis-treated cells could have been a result of intensive
stress that consequently had p53-promoted induction of
pro-oxidant proteins.
The treatments also induced TNF activation and, con-
sequently, an increase of c-jun and c-fos expression
(Fig. 1d and Additional file 1: Figure S1). Upregulation
of these markers is associated with inflammatory onset,
largely demonstrated during manifestation of the anisa-
kid infection [4], and not the apoptosis, which would
have been expected at first glance. The main difference
between ES and EC was in strong upregulation of TNF,
c-jun and c-fos in the former, and Hsp70 in the latter.
Tumor necrosis factor TNF-α is implicated in a wide
array of physiological functions, infections, autoimmune
disorders and carcinogenesis, as a pleiotropic proinflam-
matory cytokine [65]. The interaction between TNF-α
and its receptors Tumor Necrosis Factor Receptor 1
(TNFR1) and Tumor Necrosis Factor Receptor 2
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(TNFR2) [66], starts a multiple intracellular signaling
that activates among others, NF-κb pathway and specific
mitogen-activated protein kinases (MAPK) as p38 and
Jun N-terminal kinase (JNK) [67]. Cell response to such
activation will depend on a fine interaction between
apoptotic and anti-apoptotic mechanisms; if the TNFR1
intracellular domain called Death Domain (DD) specific
molecular adaptors are relegated, signal transduction to-
wards apoptosis will be activated. In contrast, when the
TNF Receptor Associated Factor (TRAF) protein family
is activated, it induces activation of transcription factors
like NF-κb and JNK that consequently activate nuclear
transcription complex AP1 (Activator Protein-1), com-
posed of subunit c-jun and c-fos. These are factors im-
portant in normal cell survival, proliferation, cell cycle
progression and inflammatory and immune response
[68]. However, they are sensitive to changes in cell redox
balance [69] and their transcriptional activities are par-
ticularly enhanced in uncontrolled tumor cell prolifera-
tion [70, 71]. Apparently, induction of redox-sensitive
pathways during tumor cell proliferation is necessary,
because the process itself demands increased energy re-
quirements and consequent increased production of
ROS metabolites might damage proliferating tumor cells
[72]. This indicates that TNF induced by ES Anisakis
products is not a prerequisite of apoptosis, but an early
hallmark for consequent activation of kinases that sup-
ports inflammation and cell proliferation. This is con-
gruent with [73], who observed that A. simplex larvae
activate human eosinophils by phosphorylation of p38
MAPK and superoxide anion production, consequently
increasing expression of surface receptors CD11b and
CD69 on eosinophils and their degranulation. The au-
thors suggested that p38 MAPK-mediated ROS produc-
tion is required for the Anisakis-induced activation of
eosinophils. However, we need to underline that, if c-jun
(upregulated in ES-treated cells) undergoes phosphoryl-
ation at 63 and 73 serine site, instead of cell prolifera-
tion, c-jun induces anti-apoptotic protection [74]. As we
are not able to discern between downstream fate of c-
jun, we would refer to ES products to have cell prolifera-
tive and anti-apoptotic effect.
Although the same targets (c-jun and c-fos) are
expressed in EC-treated cells, they show lower levels
compared to ES-treated cells, while TNF is markedly
downregulated. This suggests other signaling pathways
involved in cell reaction to EC that do not result in
cell proliferation but inhibition of apoptosis, as
marked by strong upregulation of Hsp70 (Fig. 2). In
lymphoma and myelogenous leukemia cells, suppres-
sion of TNF and another proinflammatory cytokine
interleukin 1 (IL-1) were shown to downregulate the
expression of active NF-κB and consequently inhibit
tumor growth [75]. Additionally, a mild oxidative
stress would lead to modest NF-κB activation, while
extensive oxidative stress as observed in EC-treated
cells could inhibit NF-κB [76], further supporting the
inhibition of cell proliferation.
Fig. 2 Putative pathways of normal fibroblast HS-68 cell lines response after exposure to Anisakis excretory/secretory (ES) and crude extract (EC) products.
Red arrowheads turned up or down represent significantly upregulated or downregulated markers respectively, and white smaller arrowheads represent
moderately upregulated proteins and genes
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Therefore, while EC-treated cells do not show highly
elevated markers for cell proliferation, they do show ac-
tivation of Hsp70, supportive of the apoptosis inhibition.
Its role in numerous conditions related to stress, includ-
ing the oxidative stress, as well as its capacity to prevent
cell death by apoptosis has been widely reported [77,
78]. During over-expression, Hsp70 relegates the proa-
poptotic Bax protein avoiding the formation of apopto-
some, and the activation of caspases, which trigger
apoptosis [78, 79]. This is in line with the composition
of EC reported previously. Namely, two allergens - Ani s
4 and Ani s 6, both isolated from the parasite crud ex-
tract [80, 81], have been reported to act as inhibitors of
cysteine protease [35, 37], a group also encompassing
caspases, suggesting a role in blocking apoptotic signal
transduction. Similarly, it was demonstrated that a ro-
dent malaria parasites Plasmodium yoelii blocks apop-
tosis in the majority of infected hepatocytes that also
resist Fas-mediated apoptosis (or tumor necrosis factor
receptor superfamily member 6; TNFRSF6). In contrast,
apoptosis was dramatically increased in hepatocytes in-
fected with attenuated parasitic liver stages, suggesting
that an anti-apoptotic host environment favors parasite
survival [82]. There are cases where parasite-mediated
induction of apoptosis helps larval stages to evade hu-
mane immune cells and establish the infection, as in the
lung fluke Paragonimus westermani whose metacercarial
excretory and secretary products induce caspase-3 in
man eosinophils [83]. However, in the case of non-
permissive hosts, host-mediated apoptosis induces apop-
tosis in the parasite, resulting in its successful elimin-
ation. This has been observed in the reed vole, Microtus
fortis and S. japonicum system, the former recognised as
the only mammalian host in which schistosomes fail to
mature or cause significant pathology [84]. This suggests
that interaction through apoptotic pathways of both the
parasite and its host are likely dependent upon the tight-
ness of their evolutionary history, sometimes promoting
parasite infection, sometimes inhibiting it; the actual role
of these complex pathways in Anisakis infection still re-
main to be studied.
In contrast to ES, EC-treatment demonstrated an in-
creased concentration-dependent toxicity manifested as
elevated cell mortality and ROS production. In such
toxic conditions cells are directed towards the inhibition
of apoptosis, and not towards inflammation or prolifera-
tion, which would represent potential alternatives or
cells’ safeguard paths, as observed in ES-treatment
(Fig. 2).
Finally, significant induction of p53 in fibroblasts
treated by both product types was expected and sup-
ports the behavior of above discussed cell markers. Being
a typical marker of cell response to a variety of stressors,
activated at specific check points during cell transition
through G1/S, G2/M and M phase of the cycle in case
of DNA damage [85], it provides evidence of a signifi-
cantly negative effect on the DNA induced by Anisakis
products. In an extremely pro-oxidative condition (as in
EC-treated cells), oncoprotein p53 would behave as a
pro-oxidant, adding up to the elevated cell damage and
mortality. In Schistosoma haematobium-induced bladder
carcinoma, p53 has been connected to aggressive
urothelial and squamous cell carcinomas, as well as in
non-malignant parasite-infected tissues, suggesting its
potential as a diagnostic marker for early detection of
Schistosoma-infected patients at risk of developing of
bladder cancer [86]. Similar approach could be useful in
case of patients with incidence of chronic anisakiasis.
Conclusions
Our observations are in line with the research of larval
products biochemistry supporting that Anisakis sp. ES
products contain pro-inflammatory molecules [87] that
are able to diverge ES-treated cells towards inflamma-
tion, cell proliferation and inhibition of apoptosis. The
presence of highly toxic substances contained in the
nematode cuticle and body (EC) [88] instead, redirects
fibroblasts towards the inhibition of apoptosis during a
chronic infection.
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